On June 1, more than 25,000 cancer specialists will come together at the 2012 American Society of Clinical Oncology Annual Meeting in Chicago. With ASCO hours away, we look at some small biotech companies making headway in cancer treatment.
Biovest has developed a patient-specific, cancer vaccine, BiovaxID®, with three clinical trials completed.
OneMedPlace kicked off OneMedForum NY 2012 with an exclusive investor networking reception to raise awareness about the upcoming 3rd annual finance conference.
NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for antiviral therapy.
Synthetic Biologics (SYN) is a biotechnology company focused on the development of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses.
This week, OneMedRadio brings you two management interviews. Iconic Data, CEO David LaBorde discusses their lead product SwiftPayMD and why it is changing the face […]
The company’s lead product, SwiftPayMD is a recently launched mobile app for iPad and iPhone that helps doctors work more efficiently when seeing patients at the hospital.
OneMedResearch recently initiated coverage on Opexa Therapeutics, a biotechnology company developing patient-specific cellular therapies for the treatment of autoimmune diseases.
Part II discusses The Waiting Room and the introduction of health tablets as a replacement to magazines making a patient visit more informative and efficient.
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
Copyright © 2024 | WordPress Theme by MH Themes